Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03455829 |
|---|---|
| Brief Title: | G1T38, a CDK 4/6 Inhibitor, in Combination With Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer |
| First Submitted : | February 28, 2018 |
| First Submitted that Met QC Criteria : | February 28, 2018 |
| First Posted : | March 7, 2018 |
| Results First Submitted : | December 13, 2022 |
| Results First Posted with QC Comments : | January 6, 2023 |
| Results First Submitted that Met QC Criteria : | April 7, 2023 |
| Results First Posted : | May 1, 2023 |
| Last Update Submitted that Met QC Criteria : | May 3, 2023 |
| Last Update Posted : | May 6, 2023 |